Kishore Jayakumar: Is it time to expand immunisation mandates in the US?

Though vaccines are among the most successful public health interventions in history, childhood vaccine refusal among parents is increasingly prevalent in the United States. Vaccine refusal increases the risk of developing a vaccine-preventable disease both for unvaccinated children and fully vaccinated individuals living in the area. According to the 2015 National Immunisation Survey, only 91.9 […]

Read More…

Diana Zuckerman: How to kill Obamacare—death by 1,000 cuts?

As a presidential candidate and as president of the US, Donald Trump repeatedly claimed that “Obamacare is imploding.” For months, the Trump Administration has tried to make that prediction come true. Thanks to the efforts of many healthcare advocates and policymakers, the Affordable Care Act (aka Obamacare, or the ACA) hasn’t imploded. But the Trump […]

Read More…

Doctors need to speak up against the use of mental illness as an insult

Arash Javanbakht and Aislinn Williams Over recent months ongoing shakeups in the White House staff have generated a lot of attention from the news media. However, over the summer there was one specific item of news related to psychiatry that got obscured in the whirl of other notable news surrounding it. In July, Ryan Lizza reported that […]

Read More…

Peter Doshi: Speed vs safety in the FDA’s new drug approvals—speed wins, again

In the late 1980s, AIDS activists stormed the headquarters of the US Food and Drug Administration (FDA) with a message that the FDA’s drug approval process was, simply put, killing people by blocking the approval of new treatments. One protester’s shirt read: “If I die of AIDS—forget burial—just drop my body on the steps of […]

Read More…

Joel Lexchin: We’ve missed an opportunity to debate FDA funding and user fees

In mid-August 2017, Donald Trump, the President of the United States, signed the FDA Reauthorization Act 2017, under which drug and device makers pay the FDA a fee for every new product application. User fees have been a significant component of FDA funding since the passage of the Prescription Drug User Fees Act in 1992. […]

Read More…